4.3 Letter

Ferritin Increase in Hemochromatosis Subjects After Discontinuing Their Regular Maintenance Treatment: A Longitudinal Analysis Performed During the COVID-19 Imposed Hospital Lockdown

Related references

Note: Only part of the references are listed.
Article Hematology

Hemochromatosis classification: update and recommendations by the BIOIRON Society

Domenico Girelli et al.

Summary: Hemochromatosis is a genetically heterogenous disorder characterized by uncontrolled intestinal iron absorption leading to iron overload and potentially life-threatening complications. Recent research has identified mutations in at least 5 genes as the main cause of the disease, affecting hepcidin production or action.

BLOOD (2022)

Article Gastroenterology & Hepatology

Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers

Yves Deugnier et al.

JOURNAL OF HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

Paul Adams et al.

HEPATOLOGY INTERNATIONAL (2018)

Article Biochemistry & Molecular Biology

EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)

Graca Porto et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2016)

Article Gastroenterology & Hepatology

Evidence for Distinct Pathways of Hepcidin Regulation by Acute and Chronic Iron Loading in Mice

Emilio Ramos et al.

HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

EASL clinical practice guidelines for HFE hemochromatosis

JOURNAL OF HEPATOLOGY (2010)

Article Urology & Nephrology

Kidney and anemia in familial amyloidosis type I

I Beirao et al.

KIDNEY INTERNATIONAL (2004)